Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

ÈĵξǼºÁ¾¾çÀÇ º´¸®ÇÐÀû °Ë»ö Pathological Study of Malignant Tumors of Larynx

´ëÇѺ´¸®ÇÐȸÁö 1986³â 20±Ç 3È£ p.313 ~ 321
±è¿µ¹Î, ÇÔÀDZÙ,
¼Ò¼Ó »ó¼¼Á¤º¸
±è¿µ¹Î (  ) 
¼­¿ï´ëÇб³

ÇÔÀDZ٠(  ) 
¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç

Abstract

¿ä¾à ¹× °á·Ð
1976³â 1¿ùºÎÅÍ 1985³â 12¿ù±îÁö ¸¸ 10³â µ¿¾È ¼­¿ï´ëÇб³º´¿ø¿¡¼­ »ý°Ë ¶Ç´Â ÀýÁ¦·Î È®
ÁøµÈ ÈĵξǼºÁ¾¾ç 359¿¹ (87¿¹ ÀýÁ¦)¸¦ ´ë»óÀ¸·Î º´¸®ÇÐÀû °Ë»öÀ» ½ÃÇàÇÏ°í ÀÓ»ó ±â·ÏÀ»
°ËÅäÇÏ¿© ´ÙÀ½°ú °°Àº °á·ÐÀ» ¾ò¾ú´Ù.
1) ÃÑ 359¿¹ Áß ¿ø¹ß¼º ¾Ç¼ºÁ¾¾ç 356¿¹, ÀüÀ̼º ¾Ç¼º Á¾¾ç 3¿¹¿´À¸¸ç, ¿ø¹ß¼ºÀº ÆíÆò»óÇÇ
¼¼Æ÷¾ÏÁ¾ÀÌ 348¿¹(97.8%)ÀÌ°í, ¿ì»ó¾ÏÁ¾, ¾Ç¼º¸²ÇÁÁ¾ ¹× ¹ÌºÐÈ­¾ÏÁ¾ °¢ 2¿¹, ¼±»ó³¶¼º¾ÏÁ¾
¹× À°Á¾ °¢ 1¿¹¿´À¸¸ç, ÀüÀ̼ºÀº ½Å¼¼Æ÷¾ÏÁ¾, ¾Ç¼º½Å°æÃÊÁ¾, ½ÄµµÆíÆò»óÇǼ¼Æ÷¾ÏÁ¾ °¢ 1¿¹¿´
´Ù.
2) ¿ø¹ß¼º ÆíÆò»óÇǼ¼Æ÷¾ÏÁ¾ÀÇ ³²³àºñ´Â 7.8 : 1, ¹ß»ý Æò±Õ¿¬·É 58.2¼¼(35¡­87fl)À̾ú°í, ºÎ
À§¿¡ µû¸¥ ¹ß»ýºÐÆ÷´Â ¼º¹®»óºÎ(54.1%)¿¡¼­ Á¦ ÀÏ ³ô¾ÒÀ¸¸ç, ¼º¹®ºÎ, °æ¼º¹®ºÎ, ¼º¹®ÇϺÎÀÇ
¼ø¼­¿´À¸¸ç, Á¶Á÷ º´¸®ÇÐÀûÀ¸·Î °íºÐÈ­µµ(72.7%)°¡ ´ëºÎºÐÀ̸ç ÁߺÐÈ­µµ, ÀúºÐÈ­µµÀÇ ¼øÀ̾ú
°í, Á¾¾çµî±Þ(Stage)¥², ¥³°¡ ¸¹¾Ò°í ¥°, ¥±°¡ Àû¾úÀ¸¸ç, ¼º¹®»óºÎ Á¾¾çÀÌ ¼º¹®ºÎ Á¾¾çº¸´Ù
Á¾¾çµî±ÞÀÌ ºñ±³Àû ³ô¾Ò´Ù.
3) ¿ø¹ß¼º ÆíÆò»óÇǼ¼Æ÷¾ÏÁ¾ÀÇ ÁÖ¼Ò(chief complaint)¿¡¼­ ¾Ö¼º(hoarseness)ÀÌ Á¾¾ç¹ß»ý ºÎ
À§¿¡ °ü°è¾øÀÌ °¡Àå ¸¹¾Ò°í, ¼º¹®»óºÎ ¹ß»ý ¿¹¿¡¼­ ¾Ö¼º ¿Ü¿¡ °æºÎ ºÒÄè°¨, °æºÎÁ¾±«, µ¿Åë,
ȣȩ°ï¶õ, ¿¬ÇÏ°ï¶õ, À̹°°¨ÀÇ ¼ø¼­·Î ´Ù¾çÇÏ°Ô ³ªÅ¸³µÀ¸¸ç, ù Áõ»ó ÈÄ ³»¿ø ±â°£Àº Æò±Õ 7
34°³¿ùÀÌ°í ±× Áß 3°³¿ù ÀÌÇÏ°¡ 45.5%À̾ú´Ù.
4) ¿ø¹ß¼º ÆíÆò»óÇǼ¼Æ÷¾ÏÁ¾À¸·Î ¿Ü°úÀû ÈĵΠÀýÁ¦ÇÑ 87¿¹¿¡¼­ À°¾È ÇüÅ´ ±Ë¾çµ¹ÃâÇü
49.4%, ±Ë¾çħ½ÀÇü 47.1%, ÆíÆòÇü 3.5%¿´À¸¸ç, Á¾±«ÀÇ Å©±â´Â 1.5cmÀÌÇÏ 30%, 1.6cmÀÌ»ó
70%¿´°í, ħ½À Á¤µµ´Â ÈĵÎÁ¡¸·ÇϱîÁö ħ½ÀÇÑ ¿¹°¡ °¡Àå ¸¹¾Ò°í, ÈĵΠ¿¬°ñ, Èĵΰñ°Ý±Ù, ÁÖ
À§ ¿¬ºÎÁ¶Á÷±îÁö ħ½ÀÀÇ ¼ø¼­·Î ¸¹¾Ò´Ù. ÀÌ 87¿¹ Áß ¸²ÇÁÀý ÀýÁ¦¸¦ ¼ö¹ÝÇÑ 65¿¹ ¿¡¼­ 25¿¹
(38.5%)°¡ ¸²ÇÁÀý ÀüÀ̸¦ º¸¿´°í, Á¾¾ç ¹ß»ýºÎÀ§¿¡ µû¶ó ÀüÀ̸¦ ºÐ¼®ÇÏ¸é ¼º¹®»óºÎ, °æ¼º¹®
ºÎ, ¼º¹®ÇϺÎ(50¡­60%)°¡ ¸¹¾Ò°í ¼º¹®ºÎ´Â Àû¾úÀ¸¸ç, À°¾È ÇüÅ¿¡ µû¶ó º¸¸é ±Ë¾çħ½ÀÇü
(47.1%)ÀÌ °¡Àå ¸¹¾Ò°í ÆíÆòÇüÀº ¾ø¾úÀ¸¸ç, Á¾±«ÀÇ Å©±â°¡ Ŭ¼ö·Ï ÀüÀ̵µ°¡ ³ô¾Ò°í ºÐÈ­µµ
°¡ ³ª»Ü ¼ö·Ï ÀüÀ̵µ°¡ ³ôÀ½À» º¸¿´´Ù.
5) Èí¿¬·ÂÀÌ È®ÀÎµÈ 140¿¹ Áß 8¿¹(5.7%)ÀÇ ºñÈí¿¬±ºÀ» Á¦¿ÜÇÑ Èí¿¬±ºÀÇ Èí¿¬·® Æò±ÕÀÌ
35.39°©-³â¿´À¸¸ç,20¡­40°©-³âÀÌ 57.2%¸¦ Â÷ÁöÇÏ¿´´Ù.
6) ÈĵξǼºÁ¾¾ç¿¡¼­ ¿ø°Ý ÀüÀÌ ÇÑ 8¿¹ ´Â ¸ðµÎ ÆíÆò »óÇÇ ¼¼Æ÷¾ÏÁ¾À̾úÀ¸¸ç Æó, ³ú, °£,
ôÃßÀÇ ¼øÀ̾ú°í Æó¿Í ³ú¿¡ µ¿½Ã¿¡ ÀüÀÌµÈ 3¿¹°¡ ÀÖ¾ú´Ù. ÈĵΠÆíÆò»óÇǼ¼Æ÷¾ÏÁ¾¿¡¼­ º´¹ß
¼º ¾Ç¼ºÁ¾¾çÀ» °¡Áø 8¿¹°¡ ÀÖ¾ú´Âµ¥, Æó¾Ï 5¿¹, À§¾Ï 2¿¹, ÃéÀå¾Ï 1¿¹ ¹× °©»ó¼±¾Ï 1¿¹·Î, ±×
Áß 1¿¹¿¡¼­´Â ÈĵξÏ, Æó¾Ï ¹× À§¾ÏÀÇ »ïÁß º´¹ßµµ ÀÖ¾ú´Ù.
7) Ä¡·á ÈÄ 6-53°³¿ù(Æò±Õ 25.8°³¿ù)°æ°ú ÃßÀûÇÑ 115¿¹¿¡¼­, Àç¹ßÀ̳ª ÀüÀÌ ¾øÀÌ »ì°í ÀÖ
¾ú´ø ¿¹°¡ 62¿¹(53.9%)¿´°í, Ä¡·á ÈÄ Àç¹ßÀº 2¡­34°³¿ù (Æò±Õ 12.0°³¿ù)¿¡ ³ªÅ¸³µÀ¸¸ç, Àç¹ß
ȤÀº ¿ø°ÝÀüÀÌ°¡ È®ÀÎµÈ ´ÙÀ½ ÃßÀûÁö Áߴܵǰųª »ç¸ÁÀÌ È®ÀÎµÈ ¿¹°¡ 46.1%¿´´Ù.
#ÃÊ·Ï#
A total of 359 cases of malignant tumors of the larynx(including 87 resected cases)
obtained from the pathology file of the Department of Pathology, College of Medicine,
Seoul National University during a period of 10 years from 1976 to 1985 were studied
by histopathologic and gross investigation with analysis of clinical records, with
following results.
1) Out of 359 cases, 356 cases were primary and 3 cases were metastatic. The
primary malignant tumors consisted of 348 cases (97.8%) of squamous cell carcinoma,
each 2 cases of verrucous carcinoma, malignant lymphoma and undifferentiated
carcinoma, a case of adenoid cystic carcinoma and a case of unclassified sarcoma. The
metastatic malignant tumors were each one case of renal cell carcinoma, malignant
schwanoma and esophageal squamous cell carcinoma.
2) In primary squamous cell carcinoma, the ratio of male to female was 7.8:1 and
mean age was 58.2 years(35-87 years). The location was in order of the supraglottic
(54.1%), the glottic (25.0%),the transglottic (18.0%), and the subglottic (2.9%). The
degree of histologic differentiation was in order of well (72.7%), moderate(23.6%) and
poor(3.7%). The tumor stage was stage I in 7.8% of cases, Stage ¥± 19.7%, stage ¥²
38.5%, and stage ¥³ 34.0% , and the supraglottic tumors were relatively higher grade
than the glottic tumors.
3) The chief complaints of the primary squamous cell carcinoma were mostly
hoarseness (70.9% in total case, 49.2% in the supraglottic, 90.9% in the transglottic, and
100% in the glottic and the subglottic), and were variable in the supraglottic cases in
order of sore throat, neck mass, throat pain, dyspnea, swallowing difficulty, and foreign
body sensation. The duration from the time of first symptom to vistiation was average
7.34 months and was less than 3 months in 45.6% of cases, and showed two peaks,
major in 1-2 months and minor in 10-12 months.
4) In the 87 rejected cases of primary squamous cell carcinoma, the gross pattern was
the ulcerofungating type in 49.4% of cases, the ulceroinfiltrative in 47.1% and flat in
3.5%. The size of tumor was up to 1.5 cm in 30% of cases and more than 1.6 cm in
70%. The extent of invasion was to the submucosa in 40.7% of reseated cases, to the
laungeal skeletal muscle(5) 16.3%, to the laryngeal cartilage(s)33.7%, to the perilaryngeal
soft tissue 9.3% .
In the 65 cases of lymph node dissection out of these 87 cases,25 cases (38.5%)
showed metastatic lesion(5). With relation to tumor location, lymph node metastases
were frequent in the supraglottic, the transglottic and the subglottic region (50-60%) and
less common in the glottic region (13.8%). With relation to gross pattern, the metastases
were most frequent in ulceroinfiltrative type and none in flat type. And the metastasis
rate was increased according to the increase of the tumor size and to the decrease of
the tumor differentiation.
5) Smoking history in 140 recorded cases revealed only 8 nonsmokers and average
35.39 pack-years of cigarettes in smoker group with peak in 20-40 pack-years(57.2%).
6) Distant metastases were found in 8 cases. The organs were the lung in 5 cases,
brain 4 cases, liver 1 case (Three cases were positive in two foci, the lung and the
brain). The coexistant primary malignant tumors were found in 8 cases which were 5
bronchogenic squamous cell carcinomas, 2 gastric adenocarcinoma, 1 pancreatic head
adenocarcinoma and 1 thyroid papillary carcinoma (Triple primary cancers in one case,
of the larynx, the lung and the stomach).
7) Follow, up of 6-53 months (mean 25.8 months) in 115 cases resulted in NED in 62
cases (53.9%) and expired or loss of follow, up after recurrence or distant metastasis in
53 cases (46.1%). The recurrence was detected in 2-34 months (average 12.0 months)
after treatment.

Å°¿öµå

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS